What is the latest FORTIS stock price?
The latest stored price for FORTIS is Rs 803.20 as of 2026-11-16.
FORTIS HEALTHCARE LTD is a mid-cap stock in Healthcare. This Gimli page shows the latest available FORTIS price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for FORTIS is Rs 803.20 as of 2026-11-16.
FORTIS is below 50DMA, below 200DMA. The latest 50DMA is 809.02 and the latest 200DMA is 890.69.
FORTIS has PE 57.11, ROE +10.81%, and ROCE +13.56% in Gimli's latest available snapshot.
FORTIS has returned +9.06% over 1 month, -13.54% over 3 months, and -14.34% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 2,734.83 cr | 638.94 cr | 312.38 cr | 4.14 |
| 2026-06-30 | 508.37 cr | 122.85 cr | 272.80 cr | 3.53 |
| 2026-03-31 | 2,364.67 cr | 530.45 cr | 265.85 cr | 3.52 |
| 2025-12-31 | 2,265.01 cr | 471.56 cr | 193.73 cr | 2.57 |
| 2025-09-30 | 2,331.44 cr | 606.12 cr | 321.92 cr | 4.26 |
| 2025-06-30 | 2,166.72 cr | 521.62 cr | 260.28 cr | 3.45 |
| 2025-03-31 | 2,007.20 cr | 406.34 cr | 183.89 cr | 2.44 |
| 2024-12-31 | 1,928.26 cr | 421.87 cr | n/a | nan |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 9,127.84 cr | 2,129.75 cr | 1,041.78 cr | 3.05 |
| 2025-03-31 | 7,782.75 cr | 1,577.06 cr | 774.21 cr | 10.26 |
| 2024-03-31 | 6,835.09 cr | 1,308.51 cr | 598.88 cr | 7.93 |
| 2023-03-31 | 6,213.15 cr | 1,237.80 cr | 588.73 cr | 7.80 |
| 2022-03-31 | 996.71 cr | 1,415.90 cr | -13.25 cr | 7.35 |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 15,966.23 cr | 406.97 cr | 3,472.58 cr | 10,168.51 cr |
| 2025-03-31 | 13,691.53 cr | 139.72 cr | 2,475.11 cr | 9,169.39 cr |
| 2024-03-31 | 13,288.78 cr | 235.27 cr | 1,155.02 cr | 8,556.14 cr |
| 2023-03-31 | 12,433.60 cr | 141.08 cr | 925.72 cr | 8,100.39 cr |
| 2022-03-31 | 11,884.75 cr | 143.23 cr | 1,254.93 cr | 7,008.25 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 1,601.46 cr | 656.02 cr | n/a |
| 2025-03-31 | 1,423.93 cr | 577.00 cr | n/a |
| 2024-03-31 | 1,100.10 cr | 157.63 cr | n/a |
| 2023-03-31 | 822.25 cr | 375.01 cr | n/a |
| 2022-03-31 | 865.39 cr | 649.90 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +31.17% | +23.19% | +34.46% | +26.94% | +11.18% | +0.00% |
| 2026-06-30 | +31.17% | +25.20% | +32.23% | +25.81% | +11.40% | +0.00% |
| 2026-03-31 | +31.17% | +25.97% | +31.35% | +25.72% | +11.51% | +0.00% |
| 2025-12-31 | +31.17% | +27.84% | +29.33% | +24.22% | +11.67% | +0.00% |
| 2025-09-30 | +31.17% | +27.90% | +29.14% | +24.92% | +11.79% | +0.00% |
| 2025-06-30 | +31.17% | +27.17% | +29.79% | +26.07% | +11.87% | +0.00% |
| 2025-03-31 | +31.17% | +27.40% | +29.46% | +25.77% | +11.97% | +0.00% |
| 2024-12-31 | +31.17% | +26.77% | +30.05% | +26.66% | +12.01% | +0.00% |
| 2024-09-30 | +31.17% | +25.26% | +30.73% | +27.23% | +12.84% | +0.00% |
| 2024-06-30 | +31.17% | +23.31% | +32.31% | +27.52% | +13.21% | +0.00% |
| 2024-03-31 | +31.17% | +23.24% | +31.15% | +26.51% | +14.45% | +0.00% |
| 2023-12-31 | +31.17% | +23.71% | +29.41% | +25.04% | +15.71% | +0.00% |
| 2023-09-30 | +31.17% | +26.31% | +26.55% | +22.50% | +15.97% | n/a |
| 2023-06-30 | +31.17% | +30.03% | +22.16% | +18.49% | +16.64% | +0.00% |
| 2023-03-31 | +31.17% | +31.22% | +20.70% | +17.38% | +16.92% | +0.00% |
| 2022-12-31 | +31.17% | +31.01% | +20.38% | +17.50% | +17.44% | +0.00% |
| 2022-09-30 | +31.17% | +30.59% | +20.03% | +16.89% | +18.22% | n/a |
| 2022-06-30 | +31.17% | +0.00% | +47.26% | n/a | n/a | +0.00% |
| 2022-03-31 | +31.17% | +0.00% | +46.72% | n/a | n/a | +0.00% |
| 2021-12-31 | +31.17% | +0.00% | +45.75% | n/a | n/a | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.